Diadema Partners »

Biontech Se shares owned by Diadema Partners

Quarter-by-quarter ownership of Biontech Se (BNTX) shares owned by Diadema Partners from 13F filings

Historical chart of Diadema Partners investment in Biontech Se

Tip: Access up to 7 years of quarterly data

All positions including Biontech Se held by Diadema Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Biontech Se by Diadema Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.3M 100k 93.05

More positions owned by Diadema Partners

Abivax Sa Sponsored Ads Call Option (ABVX)
Viking Therapeutics (VKTX)
Bristol Myers Squibb Put Option (BMY)
Amgen Call Option (AMGN)
United Therapeutics Corporation (UTHR)
Revolution Medicines (RVMD)
Uniqure Nv SHS Put Option (QURE)
Novartis Sponsored Adr Call Option (NVS)
Kodiak Sciences Call Option (KOD)
Capricor Therapeutics Com New Put Option (CAPR)
Cogent Biosciences (COGT)
Bridgebio Pharma Note 1.750% 3/0 (Principal)
Corcept Therapeutics Incorporated Call Option (CORT)
BioMarin Pharmaceutical (BMRN)
Kymera Therapeutics Call Option (KYMR)

View all positions for Diadema Partners

Top funds holding Biontech Se

FMR
PRIMECAP Management Company
Flossbach Von Storch
Dodge & Cox
BlackRock
Temasek Holdings
Bnp Paribas Arbitrage, Snc
Logos Global Management
Citadel Advisors
GSK
Squarepoint Ops
First Trust Advisors
Davern Capital Partners
Ubs Global Asset Management Americas
Massachusetts Financial Services

View all funds holding Biontech Se